UBQLN4 and esophageal squamous cell carcinoma: In addition, we previously demonstrated that high UBQLN4 protein levels activate alternative DDR pathways to overcome MRE11A loss and DNA damage induced by cisplatin and other DNA damage drugs; however, further studies are needed to address this and identify those oncogenic pathways reducing DNA damage in ESCC.